Aspirin reduces threat of death from prostate cancer Men with prostate tumor who take anticoagulants like aspirin in addition to radiation therapy or surgery may be able to lower their threat of dying of the condition by more than half, on November 3 according to a large study presented, 2010, at the 52nd Annual Conference of the American Culture for Radiation Oncology in NORTH PARK. The study involved a lot more than 5,000 guys with localized tumor whose disease had not spread beyond the prostate gland. Evidence has shown that anticoagulants may interfere with cancer development and spread, Kevin Choe, M suhagra .D., Ph.D., lead writer of the analysis and a radiation oncologist at University of Texas Southwestern Medical School in Dallas, said.
From the end of June, nurses will begin to record these details onto a system called VitalPAC, using the handheld gadgets. In various other hospitals where it really is used, the system has been shown to reduce the time it requires nurses to total a set of observations by up to 40 percent, reduce prices of avoidable deaths by 15 percent and decrease the average amount of stay by 10 percent. The system will be rapidly rolled out over the hospital from 29 June. Around two wards a week will begin using the system with the roll-out total in the autumn. British company The Learning Clinic developed the machine which is used across over 600 wards in 45 hospitals. It is a win-win. The system acts like an electronic personal assistant supporting our staff to ensure that every patient receives the highest standards of care all the time.